ArticleBulletin of experimental biology and medicine2025
Brain-Derived Neurotrophic Factor Cancels the Cardioprotective Effect of Interleukin-2 in a Model of Systemic Inflammatory Response in Rats.
Article in Bulletin of experimental biology and medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed, 1 synthesis or guideline pooled it.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Contradictory data about the cardioprotective and neuroprotective effects of IL-2 and BDNF and our own data on specific differences in myocardial resistance to ischemia-reperfusion after administration of exogenous IL-2 and BDNF prompted us to study the effect of combined administration of these two agents on the size of the necrosis zone in the isolated heart of rats with modeled systemic inflammatory response syndrome (SIRS). In the SIRS group, a significant increase in most proinflammatory markers in the blood and a 65% increase in the area of myocardial necrosis after ischemia-reperfusion in comparison with the control were observed. After IL-2 administration, the necrosis zone was significantly smaller than in rats with SIRS and the level of most analytes decreased. Combined administration of IL-2 and BDNF abolished the decrease in the size of the necrosis zone compared to that in rats with SIRS.
Indexed as
Identifiers
40299119What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.